The Arbiser lab has made major strides in melanoma in 2015. Honokiol, a small natural product from the Magnolia plant, was found to cause mitochondrial normalization by the Arbiser lab and other labs. Most melanomas contain Braf, and abnormal mitochondria are required for Braf to transform melanoma. The Arbiser lab has developed and patented new derivatives of honokiol. These derivatives normalize the mitochondria in aggressive melanoma cells and inhibit the growth of melanoma cells which are resistant to vemurafenib, the major drug used for melanoma. This paper has been submitted to Oncotarget. In addition, Dr Arbiser has collaborated with Dr Jing Chen to find
Read about recent studies by Dr. Jack Arbiser
Post our link on your own Facebook page by clicking on the icon below.
HELP SPREAD THE WORD!!!